Scientists Restore 2 Hours of Sleep in Alzheimer's Mice

Scientists just found a way to give back something Alzheimer's patients desperately need: restorative sleep.

Researchers at the University of Kentucky discovered that immune cells in the brain, not dying neurons or amyloid plaques, are the primary cause of sleep loss in Alzheimer's disease. By temporarily removing these cells in mice, they restored over two hours of sleep per night without changing plaque levels at all.

The finding flips everything scientists thought they knew about Alzheimer's and sleep. Dr. Shannon Macauley, who led the study, compares it to a house fire where the sprinkler system causes more damage than the flames themselves.

Microglia are the brain's immune cells, designed to protect against threats like amyloid plaques. But when they detect these sticky protein clumps, they trigger an inflammatory response that keeps the brain awake all night. "It's as if the microglia are partying all night, keeping the brain awake," Macauley explained.

The team studied mice at different ages, tracking their sleep patterns with sophisticated brain monitoring technology. They discovered something unexpected: sleep problems hit hard when plaques first appear at six months, but don't worsen even when plaque levels more than double by 18 months.

Then came the game changer. Researchers used a drug called Pexidartinib to remove 87% of the brain's immune cells for two weeks. The result was dramatic: mice with Alzheimer's gained more than two hours of sleep per night, and their deep, restorative sleep cycles normalized.

What makes this breakthrough so powerful is what it reveals about normal aging versus disease. Regular aging reduces dream sleep, but Alzheimer's specifically attacks deep, restorative sleep. That's the stage when your brain clears out toxins and consolidates memories.

The Bright Side

This discovery opens a completely new path for treating Alzheimer's sleep problems. Because the sleep loss comes from inflammation rather than plaques, it can potentially be reversed even when plaques remain.

The research team believes portable EEG systems could monitor brain activity in patients' homes, offering an affordable, noninvasive way to track disease progression and treatment response. These electrical signatures can distinguish Alzheimer's from normal aging, making diagnosis easier and more accessible.

The ultimate goal is creating tools that help human brains break what Macauley calls the "feed-forward loop." When Alzheimer's patients lose restorative sleep, they lose their brain's primary cleaning cycle, potentially driving further damage.

Restoring that sleep could give millions of patients something invaluable: the chance for their brains to heal themselves every single night.